2014
DOI: 10.1007/7854_2014_306
|View full text |Cite
|
Sign up to set email alerts
|

Interaction of Stress, Corticotropin-Releasing Factor, Arginine Vasopressin and Behaviour

Abstract: Stress mediates the activation of a variety of systems ranging from inflammatory to behavioral responses. In this review we focus on two neuropeptide systems, corticotropin-releasing factor (CRF) and arginine vasopressin (AVP), and their roles in regulating stress responses. Both peptides have been demonstrated to be involved in anxiogenic and depressive effects, actions mediated in part through their regulation of the hypothalamic-pituitary-adrenal axis and the release of adrenocorticotropic hormone. Because … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
18
0
4

Year Published

2015
2015
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 52 publications
(23 citation statements)
references
References 115 publications
(118 reference statements)
1
18
0
4
Order By: Relevance
“…Indeed, the increased PVN Fos-ir in our study might be attributed to cell types that we did not measure like corticotropin-releasing hormone (CRH). CRH is the major neuropeptide that controls pituitary ACTH secretion in response to stress in adult animals (Beurel and Nemeroff 2014; Lightman 2008). Thus, elevated Fos-ir expression might relate to PVN CRH-neuron activation.…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, the increased PVN Fos-ir in our study might be attributed to cell types that we did not measure like corticotropin-releasing hormone (CRH). CRH is the major neuropeptide that controls pituitary ACTH secretion in response to stress in adult animals (Beurel and Nemeroff 2014; Lightman 2008). Thus, elevated Fos-ir expression might relate to PVN CRH-neuron activation.…”
Section: Discussionmentioning
confidence: 99%
“…The formation of heteromers of CRHRs with other GPCRs have been proposed to govern the integration of different signal transduction systems in complex biological responses, such as HPA activation, anxiogenic behavior and drug abuse. CRH effect at the pituitary level is amplified by arginine vasopressin (AVP), which is produced in the supraoptic nucleus and PVN, co-expressed and co-secreted from hypothalamic CRH neurons ( 52 , 53 ). Both CRH and AVP neurohormones trigger different signaling pathways in pituitary corticotrophs, but the cellular mechanism underlying the synergistic effect of CRH and AVP on ACTH release is not completely understood.…”
Section: Structural and Functional Features Of Crh And Urocortins Andmentioning
confidence: 99%
“…Indeed, a similar degree of suppression of the ACTH response to CRH has been reported for patients after surgical treatment for Cushing’s syndrome and for patients after withdrawal of ≥ 2 weeks of therapeutic glucocorticoid treatment [18, 26]. The suppressed ACTH responses to CRH observed in the subacute/prolonged phases of critical illness is compatible with low endogenous CRH and/or low vasopressin signaling [27], that both can be suppressed by high circulating levels of glucocorticoids [7]. Of note, baseline plasma ACTH concentrations were not completely suppressed and slightly increased over time.…”
Section: Discussionmentioning
confidence: 56%